-
11.
公开(公告)号:AU733492B2
公开(公告)日:2001-05-17
申请号:AU3313197
申请日:1997-06-16
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , MATSUNAGA TERRY O , FRITZ THOMAS A , RAMASWAMI VARADA RAJAN
Abstract: Methods for providing an image of an internal region of a patient. Embodiments of the methods involve administering to the patient a contrast agent which comprises a vesicle composition comprising, in an aqueous carrier, a gas or gaseous precursor and vesicles comprising lipids, proteins or polymers. The patient is scanned using diagnostic imaging, such as ultrasound, to obtain a visible image of the region. The contrast agent is administered to the patient at a rate to substantially eliminate diagnostic artifacts in the image. The methods are particularly useful for diagnosing the presence of any diseased tissue in the patient.
-
12.
公开(公告)号:HK1019699A1
公开(公告)日:2000-02-25
申请号:HK99104828
申请日:1999-10-27
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , MATSUNAGA TERRY O , FRITZ THOMAS A , RAMASWAMI VARADA RAJAN
Abstract: Methods for providing an image of an internal region of a patient. Embodiments of the methods involve administering to the patient a contrast agent which comprises a vesicle composition comprising, in an aqueous carrier, a gas or gaseous precursor and vesicles comprising lipids, proteins or polymers. The patient is scanned using diagnostic imaging, such as ultrasound, to obtain a visible image of the region. The contrast agent is administered to the patient at a rate to substantially eliminate diagnostic artifacts in the image. The methods are particularly useful for diagnosing the presence of any diseased tissue in the patient.
-
13.
公开(公告)号:CA2256592A1
公开(公告)日:1997-12-24
申请号:CA2256592
申请日:1997-06-16
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , RAMASWAMI VARADA RAJAN , FRITZ THOMAS A , MATSUNAGA TERRY O
Abstract: Methods for providing an image of an internal region of a patient. Embodiments of the methods involve administering to the patient a contrast agent which comprises a vesicle composition comprising, in an aqueous carrier, a gas or gaseous precursor and vesicles comprising lipids, proteins or polymers. The patient is scanned using diagnostic imaging, such as ultrasound, to obtain a visible image of the region. The contrast agent is administered to the patient at a rate to substantially eliminate diagnostic artifacts in the image. The methods are particularly useful for diagnosing the presence of any diseased tissue in the patient.
-
-